Letters
Authors' reply
BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7034.847 (Published 30 March 1996) Cite this as: BMJ 1996;312:847
- R Madhok,
- N Maiden
- Consultant rheumatologist Senior house officer Royal Infirmary, Glasgow G4 0SF
EDITOR,—M J Shield and S V Morant agree with us about the usefulness of deriving values for the number of patients needed to be treated with misoprostol to prevent serious upper gastrointestinal complications associated with non-steroidal anti-inflammatory drugs. We disagree, however, with their criticism of our exclusion of gastrointestinal haemorrhage from the number needed to treat analysis in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.